PJP Holdings
Invesco Pharmaceuticals ETF
1W: -4.7%
1M: -7.0%
3M: +0.7%
YTD: +15.8%
1Y: +27.3%
3Y: +68.2%
5Y: +60.4%
$120.88
-0.36 (-0.30%)
Weekly Expected Move ±2.4%
$115
$118
$121
$124
$127
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$351M
Holdings28
Top 10 Wt50.0%
Beta0.46
% Profitable56%
Coverage100%
Portfolio Valuation
P/E40.1
P/B9.0
P/S6.2
EV/EBITDA22.9
P/FCF26.0
PEG5.94
Profitability & Returns
Gross Margin72.6%
Net Margin14.6%
ROE21.4%
ROA6.9%
ROIC15.6%
Div Yield1.63%
Leverage & Liquidity
Debt/Equity1.20
Debt/Assets0.38
Net Debt/EBITDA2.2x
Interest Cov8.2x
Current Ratio1.26
Quick Ratio0.99
Growth (YoY)
Revenue+19.7%
Net Income+31.7%
EPS+33.3%
FCF+34.8%
EBITDA+31.0%
Rev CAGR 3Y+22.2%
Quality Scores
Piotroski F6.2
Altman Z5.27
IS Quality65.5
IS Overall58.2
IS Value46.3
Median P/E17.6
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 27 | 99.9% | 19.3 |
| Financial Services | 1 | 0.1% | — |
| Other | 4 | —% | — |
Smart Money Overlap
2 holdings with signals
Showing 32 of 32 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Gilead Sciences Inc | GILD | 5.63% | $31.4M | 210,832 | -55.7 | $179.5B | Healthcare |
| 2 | Pfizer Inc | PFE | 5.61% | $31.3M | 1,097,883 | 36.7 | $158.4B | Healthcare |
| 3 | AbbVie Inc | ABBV | 5.53% | $30.9M | 118,012 | 74.0 | $464.3B | Healthcare |
| 4 | Johnson & Johnson | JNJ | 5.45% | $30.4M | 114,837 | 29.6 | $617.0B | Healthcare |
| 5 | Amgen Inc | AMGN | 5.35% | $29.8M | 70,759 | 24.8 | $217.5B | Healthcare |
| 6 | Eli Lilly & Co | LLY | 5.27% | $29.4M | 25,418 | 38.2 | $1.1T | Healthcare |
| 7 | Merck & Co Inc | MRK | 5.25% | $29.1M | 200,499 | 114.5 | $356.4B | Healthcare |
| 8 | Abbott Laboratories | ABT | 4.78% | $26.7M | 269,695 | 31.4 | $168.7B | Healthcare |
| 9 | Amneal Pharmaceuticals Inc | AMRX | 3.60% | $20.1M | 997,740 | 40.8 | $6.5B | Healthcare |
| 10 | Ligand Pharmaceuticals Inc | LGND | 3.55% | $19.8M | 63,460 | 30.3 | $6.1B | Healthcare |
| 11 | Tarsus Pharmaceuticals Inc | TARS | 3.53% | $19.7M | 250,245 | -67.0 | $3.1B | Healthcare |
| 12 | Viatris Inc | VTRS | 3.40% | $18.9M | 1,069,356 | -48.9 | $20.5B | Healthcare |
| 13 | United Therapeutics Corp | UTHR | 3.35% | $18.7M | 34,477 | 17.9 | $23.0B | Healthcare |
| 14 | Biogen Inc | BIIB | 3.28% | $18.3M | 80,985 | 38.7 | $32.5B | Healthcare |
| 15 | Perrigo Co PLC | PRGO | 3.27% | $18.2M | 1,234,781 | -1.1 | $2.0B | Healthcare |
| 16 | Harmony Biosciences Holdings Inc | HRMY | 3.23% | $18.0M | 459,045 | 12.7 | $2.3B | Healthcare |
| 17 | Innoviva Inc | INVA | 3.21% | $17.9M | 844,579 | 4.2 | $1.5B | Healthcare |
| 18 | ANI Pharmaceuticals Inc | ANIP | 3.08% | $17.2M | 236,348 | 14.9 | $1.6B | Healthcare |
| 19 | Corcept Therapeutics Inc | CORT | 2.99% | $16.7M | 144,690 | 223.5 | $12.6B | Healthcare |
| 20 | Bristol-Myers Squibb Co | BMY | 2.94% | $16.4M | 263,239 | 13.5 | $124.9B | Healthcare |
| 21 | Regeneron Pharmaceuticals Inc | REGN | 2.91% | $16.3M | 21,443 | 17.6 | $75.7B | Healthcare |
| 22 | Prestige Consumer Healthcare Inc | PBH | 2.86% | $15.9M | 347,516 | 12.6 | $2.1B | Healthcare |
| 23 | Jazz Pharmaceuticals PLC | JAZZ | 2.85% | $15.9M | 68,707 | 15.5 | $14.8B | Healthcare |
| 24 | Travere Therapeutics Inc | TVTX | 2.82% | $15.7M | 266,816 | -126.5 | $5.3B | Healthcare |
| 25 | Collegium Pharmaceutical Inc | COLL | 2.55% | $14.2M | 650,877 | 14.4 | $714M | Healthcare |
| 26 | Ocular Therapeutix Inc | OCUL | 2.26% | $12.6M | 1,643,349 | -4.9 | $1.5B | Healthcare |
| 27 | Liquidia Corp | LQDA | 1.38% | $7.7M | 253,645 | 18.3 | $2.5B | Healthcare |
| 28 | Invesco Government & Agency Portfolio | AGPXX | 0.06% | $357,410 | 357,410 | — | $79.1B | Financial Services |
| 29 | OmniAb Inc 11/02/2027 Private | — | —% | — | 39,023 | — | — | — |
| 30 | OmniAb Inc 11/02/2027 Private | — | —% | — | 39,023 | — | — | — |
| 31 | SECURITIES LENDING - BNYM Private | — | —% | $0 | 1 | — | — | — |
| 32 | USD Pending Dividends Private | — | —% | $166,564 | — | — | — | — |